Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly (2015)
- Authors:
- Autor USP: JORGE, ALEXANDER AUGUSTO DE LIMA - FM
- Unidade: FM
- DOI: 10.1007/s11102-014-0629-y
- Subjects: POLIMORFISMO; RECEPTORES DA SOMATOTROFINA; GENÓTIPOS; RESULTADO DE TRATAMENTO; AVALIAÇÃO DE PROCESSOS E RESULTADOS; ACROMEGALIA; GENÓTIPOS
- Language: Inglês
- Imprenta:
- Publisher place: Norwell, MA
- Date published: 2015
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
JALLAD, Raquel S. et al. Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly. Pituitary, v. 18, n. 5, p. 666-673, 2015Tradução . . Disponível em: http://link.springer.com/article/10.1007%2Fs11102-014-0629-y. Acesso em: 25 fev. 2026. -
APA
Jallad, R. S., Trarbach, E. B., Duarte, F. H., Jorge, A. A. L., & Bronstein, M. D. (2015). Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly. Pituitary, 18( 5), 666-673. doi:10.1007/s11102-014-0629-y -
NLM
Jallad RS, Trarbach EB, Duarte FH, Jorge AAL, Bronstein MD. Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly [Internet]. Pituitary. 2015 ; 18( 5): 666-673.[citado 2026 fev. 25 ] Available from: http://link.springer.com/article/10.1007%2Fs11102-014-0629-y -
Vancouver
Jallad RS, Trarbach EB, Duarte FH, Jorge AAL, Bronstein MD. Influence of growth hormone receptor (GHR) exon 3 and -202A/C IGFBP-3 genetic polymorphisms on clinical and biochemical features and therapeutic outcome of patients with acromegaly [Internet]. Pituitary. 2015 ; 18( 5): 666-673.[citado 2026 fev. 25 ] Available from: http://link.springer.com/article/10.1007%2Fs11102-014-0629-y - The E180splice mutation in the GHR gene causing Laron syndrome: Witness of a Sephardic Jewish exodus from the Iberian Peninsula to the New World?
- Clinical Characterization of Patients With Autosomal Dominant Short Stature due to Aggrecan Mutations
- Mutations in C-natriuretic peptide (NPPC): a novel cause of autosomal dominant short stature
- Aplicação da genética molecular no manejo dos distúrbios do crescimento
- Heterozygous Mutations in Natriuretic Peptide Receptor-B (NPR2) Gene as a Cause of Short Stature in Patients Initially Classified as Idiopathic Short Stature
- Development of a minimum dataset for the monitoring of recombinant human growth hormone (rhGH) therapy use in children with growth hormone deficiency (GHD) - a gloBE-reg initiative
- Clinical application of ACMG-AMP guidelines in HNF1A and GCK variants in a cohort of MODY families
- SCUBE3 loss-of-function causes a recognizable recessive developmental disorder due to defective bone morphogenetic protein signaling
- Novel SUZ12 mutations in Weaver-like syndrome
- Clinical and molecular analysis of pubertal control in a cohort of silver-russel and temple syndromes patients
Informações sobre o DOI: 10.1007/s11102-014-0629-y (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
